Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

Medpace Holdings Price Quote

$279.52

Medpace Holdings Key Stats

Buy
60
Medpace Holdings (MEDP) is a Buy

Day range:
$273.14 - $280.24
52-week range:
$167.00 - $287.00
Dividend yield:
0%
P/E ratio:
38.40
P/S ratio:
5.02
P/B ratio:
18.21%

Volume:
213.8K
Avg. volume:
313.6K
1-year change:
33.74%
Market cap:
$8.6B
Revenue:
$1.5B
EPS:
$8.54

How Much Does Medpace Holdings Make?

Is Medpace Holdings Growing As A Company?

  • What Is Medpace Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.28%
  • What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.08%

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went up by 1.94% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 33.74% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Is It Risky To Buy Medpace Holdings?

  • How Much Debt Does Medpace Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medpace Holdings Have?
    Cash and short term investments quarterly total is $95.2M
  • What Is Medpace Holdings’s Book Value Per Share?
    Book value per share is 15.35

Is Medpace Holdings Cash Flow Positive?

  • What Is MEDP Cash Flow From Operations?
    Cash flow from operations (TTM) is $413.7M
  • What Is Medpace Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$315.3M
  • What Is Medpace Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$35.9M

Medpace Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDP return on invested capital is 59.25%
  • What Is Medpace Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 19.6%
  • What Is MEDP Return On Equity?
    ROE is a measure of profitability and is 70.21%

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • Centene Corp (CNC)
    • Citius Pharmaceuticals Inc (CTXR)
    • Intuitive Surgical Inc (ISRG)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Renovaro Biosciences Inc (RENB)

Medpace Holdings Dividend Yield

Data Unavailable

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 8.29% 2.1%
Revenue: 28.34% 3.52%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 278.60
Downside from Last Price: -0.33%

Major Shareholders

  • How many MEDP shares are owned by institutional investors?
    288.9M MEDP shares are owned by institutional investors
  • How many MEDP shares are owned by insiders?
    874.9K MEDP shares are owned by insiders